Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AptarGroupATR +0.20%78 EV-to-OCF is 15.63 as of Jul. 23, 2026, which is 14% below its 10-year median of 18.23. GuruFocus rates ATR with a GF Score™ of 78/100 and a GF Value™ of $157.60 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 853 Medical Devices & Instruments companies, AptarGroup ranks worse than 68.7% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, AptarGroup's Enterprise Value is $9,468 Mil.
AptarGroup's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $606 Mil. Therefore, AptarGroup's EV-to-OCF for today is 15.63.
The historical rank and industry rank for AptarGroup's EV-to-OCF or its related term are showing as below:
ATR'
s EV-to-OCF Range Over the Past 10 Years
Min: 13.85 Med: 18.23 Max: 29.86
Current: 15.63
During the past 13 years, the highest EV-to-OCF of AptarGroup was 29.86. The lowest was 13.85. And the median was 18.23.
ATR's EV-to-OCF is ranked worse than 68.7% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.94
vs ATR: 15.63
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
AptarGroup's share price for today is $129.17.
AptarGroup's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.840.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
AptarGroup EV-to-OCF Related Terms
AptarGroup EV-to-OCF Historical Data
* Premium members only.
The historical data trend for AptarGroup's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, AptarGroup's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AptarGroup EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AptarGroup's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where AptarGroup's EV-to-OCF falls into.
AptarGroup's current Enterprise Value is $9,468 Mil.
AptarGroup's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $606 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AptarGroup (ATR) has a EV-to-OCF of 15.63 as of Jul. 23, 2026. This is 14% below median its historical median of 18.23. Over the past decade, AptarGroup's EV-to-OCF has ranged from 13.85 to 29.86. According to the industry distribution chart, AptarGroup ranks #586 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 68.7%.
Is AptarGroup's EV-to-OCF too high?
AptarGroup's current EV-to-OCF of 15.63 is 14% below median its 10-year median of 18.23. Over the past 10 years, this metric has ranged from a low of 13.85 to a high of 29.86. The Medical Devices & Instruments industry median EV-to-OCF is 7.94. AptarGroup's value of 15.63 is 96.9% above this industry median. Based on the distribution chart, AptarGroup ranks #586 out of 853 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, AptarGroup has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AptarGroup's EV-to-OCF compare to RGEN and AVTR?
According to the Medical Devices & Instruments industry distribution chart, AptarGroup ranks #586 out of 853 companies for EV-to-OCF. This places AptarGroup in the lower half of its industry. The industry median EV-to-OCF is 7.94. AptarGroup's value of 15.63 is 96.9% above this benchmark. Historically, AptarGroup's own EV-to-OCF has ranged from 13.85 to 29.86 over the past decade. While the company's 10-year median is 18.23 vs. the industry median of 7.94, AptarGroup has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.94, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AptarGroup's current EV-to-OCF of 15.63 is 96.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AptarGroup's current EV-to-OCF is 15.63, which is 14% below median its own 10-year median of 18.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AptarGroup stock overvalued right now?
Based on GuruFocus' analysis, AptarGroup (ATR) is currently considered Modestly Undervalued. The stock's GF Value™ is $157.60, compared to a current price of $129.17 — trading 18% below its estimated fair value. The current EV-to-OCF is 15.63, which is 14% below median its 10-year median of 18.23 and 96.9% above the Medical Devices & Instruments industry median of 7.94. AptarGroup's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For AptarGroup (ATR), the current EV-to-OCF is 15.63 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AptarGroup (ATR) Overvalued in 2026?
Based on GuruFocus' analysis, AptarGroup stock appears to be undervalued.
The current stock price of $129.17 is trading 18% below its estimated GF Value™ of $157.60.
GuruFocus considers AptarGroup to be Modestly Undervalued.
Key valuation signals for ATR:
EV-to-OCF: 15.63 (14% below median its 10-year median of 18.23)
GF Value™: $157.60 vs. price of $129.17 (18% below fair value)
Industry Position: 96.9% above the Medical Devices & Instruments median (#586 of 853)
No single metric tells the full story. See the ATR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
78GF Score
Get the complete analysis for ATR
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ATR has been successfully added to your 
